Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/05/1999 | US5962289 Polysaccharide binding fusion proteins and conjugates |
10/05/1999 | US5962283 Transminases and amnotransferases |
10/05/1999 | US5962281 Process for preparing L-tertiary-leucine and L-phosphinothricine by transamination |
10/05/1999 | US5962273 Detection of Neisseria gonorrhoeae by amplification and detection of its nucleic acid |
10/05/1999 | US5962272 Methods and compositions for full-length cDNA Cloning using a template-switching oligonucleotide |
10/05/1999 | US5962271 Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end |
10/05/1999 | US5962270 Transforming host cell with vector encoding a fusion protein of carbonic anhydrase, linker peptide, and calcitonin; culturing cell to express fusion protein, cleaving protein with hydroxylamine at linker peptide |
10/05/1999 | US5962269 Methods for producing antibodies which specifically bind to interleukin-9 receptor |
10/05/1999 | US5962268 DNA encoding an immune cell cytokine |
10/05/1999 | US5962267 Proinsulin derivative and process for producing human insulin |
10/05/1999 | US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system. |
10/05/1999 | US5962264 Method of reducing the proteolytic degradation of bacillus thuringiensis insecticidal toxic protein |
10/05/1999 | US5962261 Polynucleotides encoding a neuronal extracellular matrix protein |
10/05/1999 | US5962260 Recombinant production of human and bovine receptors for modified low-density lipoprotein |
10/05/1999 | US5962259 Response regulator polynucleotides |
10/05/1999 | US5962258 Carboxymethyl cellulase fromthermotoga maritima |
10/05/1999 | US5962257 Flea aminopeptidase nucleic acid molecules |
10/05/1999 | US5962256 Nuclear thyroid hormone receptor-interacting polynucleotides and related molecules and methods |
10/05/1999 | US5962249 Sized-based marker identification technology |
10/05/1999 | US5962240 Mycobacterium proteins and applications |
10/05/1999 | US5962237 Method of enriching rare non-blood cells such as cancer cells, from bodily fluids, such as blood. |
10/05/1999 | US5962236 Immunoassay using antibodies against free lysyl pyridinoline cross-links in unhydrolyzed urine sample |
10/05/1999 | US5962232 Protein kinase molecules |
10/05/1999 | US5962230 Diagnosis and treatment of glaucoma |
10/05/1999 | US5962229 This invention is in the field of plant molecular biology, and pertains to nucleic acid fragments encoding maize glutathione-s-transferase (gst) enzymes involved in the detoxification of xenobiotic compounds in plants and seeds. |
10/05/1999 | US5962226 Human RNA-binding protein |
10/05/1999 | US5962225 The present invention can be performed on large amounts of purified dna in a single test, with high levels of sensitivity, thus eliminating the need for dna amplification procedures. |
10/05/1999 | US5962219 Systematic evolution of ligands by exponential enrichment: chemi-selex |
10/05/1999 | US5962217 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof |
10/05/1999 | US5961983 Stable pura vectors and uses therefor |
10/05/1999 | US5961982 Recombinant herpesvirus of turkeys and uses thereof |
10/05/1999 | US5961976 Monoclonal antibodies characterized by their ability to neutralize in vitro and in vivo primary isolates of human immunodeficiency virus (hiv) and related immunodeficiency viruses. |
10/05/1999 | US5961974 This invention provides isolated human and murine cd40-l polypeptides that bind to the extracellular binding region of a cd40 receptor. the present invention relates to a novel cytokine. |
10/05/1999 | US5960976 For heating a sample stored |
10/05/1999 | CA2161962C Adenovirus vectors for gene therapy |
10/05/1999 | CA2067176C Recombinant gene coding for a protein having an endochitinase activity |
10/05/1999 | CA2004646C Protease, reverse transcriptase and endonuclease of retrovirus, and method for producing these enzymes |
10/05/1999 | CA1340779C Plasmids causing densunucleosis; process for preparing the same and their use for the biological control of insect pests |
10/05/1999 | CA1340776C Multispecific antigenic proteins |
10/01/1999 | CA2249043A1 Novel compounds |
09/30/1999 | WO1999049403A1 System and methods for analyzing biomolecular sequences |
09/30/1999 | WO1999049316A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
09/30/1999 | WO1999049294A2 Assay methods |
09/30/1999 | WO1999049083A1 Diagnosis of disease state using mrna profiles in peripheral leukocytes |
09/30/1999 | WO1999049079A1 Rolling circle replication of padlock probes |
09/30/1999 | WO1999049067A1 Nucleic acid transfer vectors, compositions containing same and uses |
09/30/1999 | WO1999049066A1 Method for ballistic transformation of caenorhabditis elegans |
09/30/1999 | WO1999049065A1 Antisense modulation of human mdm2 expression |
09/30/1999 | WO1999049064A2 Plant control genes |
09/30/1999 | WO1999049063A1 Protein expression in floral cells |
09/30/1999 | WO1999049061A1 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use |
09/30/1999 | WO1999049058A2 Tryptophan biosynthetic enzymes |
09/30/1999 | WO1999049057A1 Serine protease variants having amino acid deletions and substitutions |
09/30/1999 | WO1999049056A1 Serine protease variants having amino acid substitutions |
09/30/1999 | WO1999049055A1 Human casb12 polypeptide, a serine protease |
09/30/1999 | WO1999049054A1 Diagnostics and vaccines for mycobacterial infections of animals and humans |
09/30/1999 | WO1999049053A1 Lcb1 subunit of serine palmitoyltransferase |
09/30/1999 | WO1999049052A2 Processive glycosyltransferase |
09/30/1999 | WO1999049051A1 LIPOPOLYSACCHARIDE α-2,3 SIALYLTRANSFERASE OF CAMPYLOBACTER JEJUNI AND ITS USES |
09/30/1999 | WO1999049050A2 Limanthes oil genes |
09/30/1999 | WO1999049049A1 Streptococcus sag-a, a structural protein associated with sls activity |
09/30/1999 | WO1999049048A1 Identification genes and gene products involved in cytoadherance of plasmodium infected erythrocytes |
09/30/1999 | WO1999049047A2 Plant 1,3-beta-d-glucan synthase and brittle-1 encoding sequences |
09/30/1999 | WO1999049046A1 Signal transduction protein involved in plant dehiscence |
09/30/1999 | WO1999049045A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
09/30/1999 | WO1999049044A1 Cardiostatin polypeptides and polynucleotides |
09/30/1999 | WO1999049043A2 Human rad17 cell cycle checkpoint |
09/30/1999 | WO1999049042A1 HUMAN Rad1 CELL CYCLE CHECKPOINT |
09/30/1999 | WO1999049041A1 Drm, a secreted protein with cell growth inhibiting activity, and related methods and compositions |
09/30/1999 | WO1999049040A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb |
09/30/1999 | WO1999049039A2 GFRα3 AND ITS USES |
09/30/1999 | WO1999049038A2 Human calcium-binding proteins |
09/30/1999 | WO1999049037A2 Protein phosphatase-related molecules |
09/30/1999 | WO1999049036A1 Lepidopteran gaba gated chloride channel and methods of use thereof |
09/30/1999 | WO1999049035A2 Insecticidal compounds from segestria florentina |
09/30/1999 | WO1999049034A1 Breast cancer antigen |
09/30/1999 | WO1999049033A1 Casb414: antigen overexpressed in several tumors |
09/30/1999 | WO1999049032A1 Suppressors of cytokine signalling |
09/30/1999 | WO1999049031A1 Use of nucleic acid molecules as antiviral agents |
09/30/1999 | WO1999049030A1 Compounds related to pap-1 |
09/30/1999 | WO1999049029A1 Control of gene expression |
09/30/1999 | WO1999049028A1 Method of selection for genes encoding secreted and transmembrane proteins |
09/30/1999 | WO1999049027A1 Methods for prevention and treatment of cancer |
09/30/1999 | WO1999049026A1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
09/30/1999 | WO1999049025A2 Human vault rna |
09/30/1999 | WO1999049024A2 Methods and compositions for production of multimeric proteins in transgenic plants |
09/30/1999 | WO1999049023A1 The cytokine family member 2-21 |
09/30/1999 | WO1999049022A1 Phytase variants |
09/30/1999 | WO1999049021A1 Lcb2 subunit of serine palmitoyltransferase |
09/30/1999 | WO1999049020A2 Phenol oxidizing enzyme enzymes |
09/30/1999 | WO1999049019A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
09/30/1999 | WO1999049018A1 Glycosyl sulfotransferase-3 |
09/30/1999 | WO1999049017A2 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
09/30/1999 | WO1999049013A2 Tryptophan biosynthetic enzymes |
09/30/1999 | WO1999049010A2 Phenol oxidizing enzymes and their use |
09/30/1999 | WO1999048921A1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
09/30/1999 | WO1999048920A1 Novel physiologically active peptides and utilization thereof |
09/30/1999 | WO1999048919A1 H.pylori antigen and its use |
09/30/1999 | WO1999048918A1 Protease conjugates |
09/30/1999 | WO1999048917A2 Formulation having a papilloma virus-specific protein, and the production and use thereof |